secwatch.observer — SEC 8-K summary
======================================

Issuer:     RAPID MICRO BIOSYSTEMS, INC. (RPID)
CIK:        0001380106
Form:       8-K
Filed at:   2026-05-13T20:33:24+00:00
Accession:  0001380106-26-000067
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rapid Micro Biosystems Q1 revenue up 11% to $8.0M; net loss widens to $14.3M
----------------------------------------------------------------------------

- Total revenue $8.0M (+11% YoY); product revenue $5.6M (+36%).
- Net loss $14.3M ($0.31/sh) vs $11.3M ($0.26/sh) in Q1 2025.
- Recurring revenue $5.1M (+28%), 63% of total; placed 6 Growth Direct systems (3 in Q1 2025).
- Gross margin 4.6% vs 5.6% last year; cash and equivalents $23M.
- Reaffirms FY2026 guidance: revenue $37-41M, 30-38 system placements, ~20% gross margin.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1380106/000138010626000067/0001380106-26-000067-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1380106/000138010626000067/rpid-20260513.htm
  HTML page:      https://secwatch.observer/filing/0001380106-26-000067

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer